ARCHIVES

Abraxane Improves Progression-Free Survival Compared to Decarbazine In Stage IV Disease

This article is from The Cancer Letter archive.

Vol. 35 No. 11 | November 30, 2012

Download PDF Visit The Full Archive

Related Articles

Niederhuber: Clinical Trials System Must Refocus To Emphasize Translational Studies.

July 9, 2010

ACS Approves 127 Cancer Programs; Total Now 994

March 18, 1983

Marie Lombardi NCAB Member, Dies; HHS Holding Up Board Appointments

April 23, 1982

Amgen Replaces “Bundling” Contract With Three Separate Contracts For Growth Factors.

September 5, 2008

Indiana to Close Proton Beam Facility Amid Nationwide Building Boom

October 17, 2014

In Brief: Magnuson Subcommittee Increases NCI, NIH Budgets Despite Trimming Labor-HEW Bill By $250 Million

August 23, 1974